Eli Lilly and Co (LLY.N)
|Market Cap (Mil.):||$73,518.89|
|Shares Outstanding (Mil.):||1,117.31|
NEW YORK - U.S. stocks rose on Tuesday and the S&P notched its best performance in a month after a report shifted investor expectations for the Federal Reserve's policy statement due on Wednesday.
NEW YORK - U.S. stocks were set to open lower on Tuesday with traders positioning for a Federal Reserve meeting expected to provide clues on the short term direction of U.S. interest rates.
* Futures off: Dow 31 pts, S&P 4 pts, Nasdaq 11 pts (Updates prices, adds comment)
NEW YORK, Sept 16 - U.S. stock index futures dipped on Tuesday ahead of data on producer price inflation, with traders positioning for a Federal Reserve meeting expected to provide clues on the short term direction of U.S. interest rates.
(Adds Etihad Airways, Vodafone, Compuware Corp, Hugo Boss, Ecotpetrol, Telekom, Petrolvalves)
BRUSSELS, Sept 2 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:
BRUSSELS, Sept 1 - European Union competition regulators have until Oct. 3 to decide whether to approve U.S. drugmaker Eli Lilly and Co's $5.4 billion bid for Swiss peer Novartis's animal health business.
- Takeda Pharmaceutical Co Ltd and Eli Lilly & Co lost a bid to overturn a combined $9 billion punitive damage award by a U.S. jury for hiding cancer risks associated with their Actos diabetes drug, according to a court ruling.
Aug 28 - Takeda Pharmaceuticals and Eli Lilly & Co lost a bid to overthrow a combined $9 billion punitive-damage award by a U.S. jury for hiding cancer risks associated with their Actos diabetes drug, according to a court ruling.
- Eli Lilly and Co's quarterly revenue plunged due to generic competition for its Cymbalta depression drug and its Evista osteoporosis treatment, but cost controls helped earnings beat forecasts.
|Takeda Pharmaceutical Co Ltd (4502.T)||¥4,830||+2.50|
|Johnson & Johnson (JNJ.N)||$106.19||+0.31|
|Pfizer Inc. (PFE.N)||$30.35||+0.30|
|Novartis AG (NOVN.VX)||CHF88.90||+1.15|
|Merck & Co., Inc. (MRK.N)||$59.88||-0.11|
|Abbott Laboratories (ABT.N)||$43.38||+0.48|
|Sanofi SA (SASY.PA)||€87.53||+1.03|
|AstraZeneca plc (AZN.L)||4,493.00p||-18.50|
|GlaxoSmithKline plc (GSK.L)||1,434.00p||-7.00|
|Bristol-Myers Squibb Co (BMY.N)||$50.88||-0.27|
Earnings vs. Estimates
Analyst Research Reports
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Trading Report for (LLY). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
Provider: Wright Reports
Provider: S&P Capital IQ – STARS Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.